IIB 

114TH CONGRESS 

2D SESSION H. R. 3537 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 27, 2016 

Received; read twice and referred to the Committee on the Judiciary 

AN ACT 

To amend the Controlled Substances Act to add certain 

synthetic substances to schedule I, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


asabaliauskas on DSK3SPTVN1PROD with BILLS
2 

HR 3537 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Dangerous Synthetic 

3 Drug Control Act of 2016’’. 

4 SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS 

5 SCHEDULE I CONTROLLED SUBSTANCES. 

6 (a) CANNABIMIMETIC AGENTS.—Schedule I, as set 

7 forth in section 202(c) of the Controlled Substances Act 

8 (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)— 

9 (1) in clause (xiv) by striking ‘‘and’’ at the end; 

10 (2) in clause (xv) by striking the period and in11 serting a semicolon; and 

12 (3) by adding at the end the following: 

13 ‘‘(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H14 indol-3-yl)ethanone (JWH–251); 

15 ‘‘(xvii) (1-butyl-1H-indol-3-yl)(4- 

16 methylnaphthalen-1-yl)methanone (4′-methyl 

17 JWH–073); 

18 ‘‘(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl19 1H-indol-3-yl)ethanone (JWH–302); 

20 ‘‘(xix) N-(adamantan-1-yl)-1-(5- 

21 fluoropentyl)-1H-indole-3-carboxamide (5F– 

22 APICA); 

23 ‘‘(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H24 indole-3-carboxylate (5F–PB–22); 


asabaliauskas on DSK3SPTVN1PROD with BILLS
3 

HR 3537 RFS

1 ‘‘(xxi) N-(1-amino-3-methyl-1-oxobutan-2- 

2 yl)-1-pentyl-1H-indazole-3-carboxamide (AB– 

3 PINACA); 

4 ‘‘(xxii) N-(naphthalen-1-yl)-1-pentyl-1H5 indole-3-carboxamide (MN–24); 

6 ‘‘(xxiii) (1-(5-fluoropentyl)-1H-indazol-3- 

7 yl)(naphthalen-1-yl)methanone (THJ–2201); 

8 ‘‘(xxiv) N-(1-amino-3,3-dimethyl-1- 

9 oxobutan-2-yl)-1-pentyl-1H-indazole-3- 

10 carboxamide (ADBICA); 

11 ‘‘(xxv) methyl 2-(1-(5-fluoropentyl)-1H-in12 dazole-3-carboxamido)-3-methylbutanoate (5F– 

13 AMB); and 

14 ‘‘(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H15 indazole-3-carboxamido)-3-methylbutanoate 

16 (MA–CHMINACA).’’. 

17 (b) SYNTHETIC OPIOIDS.—Schedule I, as set forth in 

18 section 202(c) of the Controlled Substances Act (21 

19 U.S.C. 812(c)), is amended in subsection (a) by adding 

20 at the end the following: 

21 ‘‘(43) Butyryl fentanyl. 

22 ‘‘(44) beta-Hydroxythiofentanyl. 

23 ‘‘(45) Acetyl fentanyl.’’. 

24 (c) OTHER DRUGS.—Schedule I, as set forth in sec25 tion 202(c) of the Controlled Substances Act (21 U.S.C. 


asabaliauskas on DSK3SPTVN1PROD with BILLS
4 

HR 3537 RFS

1 812(c)), is amended in subsection (c) by adding at the 

2 end the following: 

3 ‘‘(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1- 

4 yl)pentan-1-one (α-naphyrone). 

5 ‘‘(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2- 

6 amine (5–APDB). 

7 ‘‘(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2- 

8 amine (6–APDB). 

9 ‘‘(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol10 6-amine (MDAI). 

11 ‘‘(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5– 

12 IAI). 

13 ‘‘(34) 1-(4-bromofuro[2,3-f]benzofuran-8- 

14 yl)propan-2-amine (bromo-dragonfly). 

15 ‘‘(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan16 2-amine (DOC). 

17 ‘‘(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan18 2-amine (MEM).’’. 

Passed the House of Representatives September 26, 

2016. 

Attest: KAREN L. HAAS, 

Clerk. 


asabaliauskas on DSK3SPTVN1PROD with BILLS